| Product Code: ETC7049686 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Egypt Malaria Vaccine Market Overview |
3.1 Egypt Country Macro Economic Indicators |
3.2 Egypt Malaria Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Egypt Malaria Vaccine Market - Industry Life Cycle |
3.4 Egypt Malaria Vaccine Market - Porter's Five Forces |
3.5 Egypt Malaria Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Egypt Malaria Vaccine Market Revenues & Volume Share, By Agent, 2021 & 2031F |
3.7 Egypt Malaria Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Egypt Malaria Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Egypt Malaria Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increase in government initiatives and funding for malaria control programs |
4.2.2 Growing awareness about the importance of vaccination in preventing malaria |
4.2.3 Technological advancements in vaccine development and production |
4.3 Market Restraints |
4.3.1 Limited accessibility and affordability of vaccines in remote areas of Egypt |
4.3.2 Lack of proper infrastructure for vaccine storage and distribution |
5 Egypt Malaria Vaccine Market Trends |
6 Egypt Malaria Vaccine Market, By Types |
6.1 Egypt Malaria Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Egypt Malaria Vaccine Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Egypt Malaria Vaccine Market Revenues & Volume, By Pre-Erythrocytic Vaccine, 2021- 2031F |
6.1.4 Egypt Malaria Vaccine Market Revenues & Volume, By Erythrocytic Vaccine, 2021- 2031F |
6.1.5 Egypt Malaria Vaccine Market Revenues & Volume, By Multi-Antigen Vaccine, 2021- 2031F |
6.2 Egypt Malaria Vaccine Market, By Agent |
6.2.1 Overview and Analysis |
6.2.2 Egypt Malaria Vaccine Market Revenues & Volume, By Plasmodium Falciparum, 2021- 2031F |
6.2.3 Egypt Malaria Vaccine Market Revenues & Volume, By Plasmodium Vivax, 2021- 2031F |
6.2.4 Egypt Malaria Vaccine Market Revenues & Volume, By Anopheles Species, 2021- 2031F |
6.3 Egypt Malaria Vaccine Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Egypt Malaria Vaccine Market Revenues & Volume, By Intramuscular, 2021- 2031F |
6.3.3 Egypt Malaria Vaccine Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.4 Egypt Malaria Vaccine Market Revenues & Volume, By Intradermal, 2021- 2031F |
6.4 Egypt Malaria Vaccine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Egypt Malaria Vaccine Market Revenues & Volume, By NGO/Non-Profit Organization, 2021- 2031F |
6.4.3 Egypt Malaria Vaccine Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.4 Egypt Malaria Vaccine Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.5 Egypt Malaria Vaccine Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Egypt Malaria Vaccine Market Import-Export Trade Statistics |
7.1 Egypt Malaria Vaccine Market Export to Major Countries |
7.2 Egypt Malaria Vaccine Market Imports from Major Countries |
8 Egypt Malaria Vaccine Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage rates in high-risk areas |
8.2 Number of research and development collaborations for malaria vaccine projects |
8.3 Improvement in healthcare infrastructure in rural regions for vaccine distribution |
8.4 Number of reported malaria cases in Egypt |
8.5 Percentage of the population receiving recommended vaccine doses |
9 Egypt Malaria Vaccine Market - Opportunity Assessment |
9.1 Egypt Malaria Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Egypt Malaria Vaccine Market Opportunity Assessment, By Agent, 2021 & 2031F |
9.3 Egypt Malaria Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Egypt Malaria Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Egypt Malaria Vaccine Market - Competitive Landscape |
10.1 Egypt Malaria Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Egypt Malaria Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here